Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Or leave a message with a formal purchase order (PO) Or credit card.
Recombinant SARS-CoV-2 Spike (His-Avi) RBD
2019-nCoV S protein RBD is expressed from mammalian with a His tag and Avi at the C-terminal.
It contains Arg319-Asn532.
The protein has a predicted MW of 27 kDa. Due to glycosylation, the protein migrates to 36-40KDa based on Bis-Tris PAGE result.
Less than 1EU per ug by the LAL method.
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). Normally 5 % trehalose is added as protectant before lyophilization.
The product should be stored at -70℃ or -20℃.
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin- converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.